AstraZeneca Expands into the Obesity Space The obesity treatment landscape continues to evolve rapidly, and AstraZenecas positive Phase II results for its oral GLP-1 therapy represent an important milestone
It offers: The highest bioavailability Direct systemic and localized benefits Backing from animal and preclinical research For Digestive Healing and Low-Grade Inflammation: Oral (Liquid or Sublingual) Oral BPC157 may help with: Gut lining repair (e.g
With reactive hypoglycaemia, blood sugar levels become unstable and spike after food
Large employers are adopting Individual Coverage Health Reimbursement Arrangements (ICHRA) at a rapidly increasing rate, with adoption growing by 84% between 2023 and 2024
That reflects a strategic shift toward using patents on drug compounds to pursue centralized sellers, said Joshua Goldberg, a patent litigator at Nath Goldberg & Meyer who focuses on chemical and pharmaceutical patents
Cellular Wellness ALA may support healthy cellular function and help protect cells from everyday oxidative stress
